Kurebayashi Y, Sugimoto K, Tsujikawa H, Matsuda K, Nomura R, Ueno A, Masugi Y, Yamazaki K, Effendi K, Takeuchi H, Itoi T, Hasegawa Y, Abe Y, Kitago M, Ojima H, Sakamoto M.: Spatial Dynamics of T- and B-Cell Responses Predicts Clinical Outcome of Resectable and Unresectable Hepatocellular Carcinoma: Clin Cancer Res 30(24):5666-5680, 2024 → Link to PubMed
Abe M, Kanavati F, Tsuneki M.: Evaluation of a Deep Learning Model for Metastatic Squamous Cell Carcinoma Prediction From Whole Slide Images: Arch Pathol Lab Med 148(12):1344-1351, 2024 → Link to PubMed
Mitsunaga S, Ikeda M, Nomura S, Morizane C, Todaka A, Yamamoto N, Kamata K, Yanagibashi H, Mizuno N, Kawamoto Y, Gotoh K, Shirakawa H, Okano N, Nomura T, Tanaka K, Takahashi A, Yagi S, Ohta K, Takayama Y, Miwa H, Nagano H, Kojima Y, Hisano T, Tahara M, Sakuma Y, Arai H, Nakamura I, Katayama H, Konishi M, Ueno M; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG‐HBPOG).: 5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1): J Hepatobiliary Pancreat Sci 31(12):886-896, 2024 → Link to PubMed
Imaoka H, Sasaki K, Machida R, Nagano H, Satoi S, Ikeda M, Kobayashi S, Yamashita T, Okusaka T, Ido A, Hatano E, Miwa H, Ueno M, Nakao K, Shimizu S, Kuramochi H, Sakamori R, Tsumura H, Okano N, Shioji K, Shirakawa H, Akutsu N, Tsuji K, Ishii H, Umemoto K, Asagi A, Ueno M; JCOG Hepatobiliary and Pancreatic Oncology Group.: Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021-22: Jpn J Clin Oncol 54(10):1071-1077, 2024 → Link to PubMed
Uojima H, Tsujikawa H, Yamazaki K, Sugiyama M, Take A, Sakaguchi Y, Gotoh K, Satoh T, Hidaka H, Hayashi S, Kusano C, Sakamoto M, Mizokami M.: Hepatic Mac2-BP expression depends on liver fibrosis and inflammation due to fat accumulation in patients with metabolic dysfunction-associated steatotic liver disease: Hepatol Res (in print) → Link to PubMed
Miura E, Emoto K, Abe T, Hashiguchi A, Hishida T, Asakura K, Sakamoto M.: Establishment of artificial intelligence model for precise histological subtyping of lung adenocarcinoma and its application to quantitative and spatial analysis: Jpn J Clin Oncol 54(9):1009-1023, 2024 → Link to PubMed
Tezuka S, Ozaka M, Furuse J, Yokoyama M, Uemura K, Sano Y, Nakachi K, Imaoka H, Unno M, Shirakawa H, Shimizu S, Kato N, Kojima Y, Sano K, Kobayashi S, Terashima T, Morizane C, Ikeda M, Ueno M.: Early tumor shrinkage as a prognostic predictor in chemotherapy-naïve patients with locally advanced pancreatic cancer treated with modified FOLFIRINOX or gemcitabine plus nab-paclitaxel combination therapy: An exploratory analysis of JCOG1407: Pancreatology 24(6):909-916, 2024 → Link to PubMed
Tsuji K, Abe M, Wakamatsu S, Hoshi S, Hoshi N, Takagi C, Fukushima N, Hirabayashi K.: Mixed hepatocellular carcinoma and high-grade neuroendocrine neoplasm with ambiguous histopathological features: a case report: Med Mol Morphol (in print) → Link to PubMed
Sungwan P, Panaampon J, Kariya R, Kamio S, Nakagawa R, Hirozane T, Ogura Y, Abe M, Hirabayashi K, Fujiwara Y, Kikuta K, Okada S.: Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line: Hum Cell 37(4):1215-1225, 2024 → Link to PubMed
Endo Y, Shinoda M, Maehara J, Hibi T, Hasegawa Y, Obara H, Kitago M, Ojima H, Tanabe M, Kitagawa Y.: Early-onset hepatic veno-occlusive disease after liver transplantation: an institutional experience and analysis of a literature-based cohort: Surg Today 54(7):670-682, 2024 → Link to PubMed
Ishii M, Hibi T.: Protein induced by vitamin-K absence II: Another key to create a common language: Liver Transpl 30(5):454-455, 2024 → Link to PubMed
Makiuchi S, Tian Y, Fujimoto M, Kuramoto J, Tsuda N, Ojima H, Gotoh M, Hiraoka N, Yoshida T, Kanai Y, Arai E.: DNA methylation alterations of ADCY5, MICAL2, and PLEKHG2 during the developmental stage of cryptogenic hepatocellular carcinoma: Hepatol Res 54(3):284-299, 2024 → Link to PubMed
Ishii M, Hirukawa K, Shimata K, Yoshimaru Y, Sagishima K, Sakurai Y, Tomita M, Isono K, Honda M, Sugawara Y, Hirata N, Tanaka Y, Hibi T.: The First Successful Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure Caused by Severe Acute Necrotizing Pancreatitis: A Case Report: Transplant Proc 56(1):239-243, 2024 → Link to PubMed
Matsuda K, Ueno A, Tsuzaki J, Kurebayashi Y, Yamazaki K, Tamura M, Jinzaki M, Abe Y, Hasegawa Y, Kitago M, Sakamoto M: Heterogeneous enhancement pattern of Gd-EOB-DTPA-enhanced MRI predicts vessels encapsulating tumor clusters (VETC)-positive hepatocellular carcinoma, American Association for Cancer Research Annual Meeting 2024, Florida, USA, 2024.04
Kubota N,Ojima H,Yamazaki K, Arai Y, Esaki M, Hiraoka N, Shibata T, Sakamoto M: Cholangiolocellular Carcinoma Component Predicts a Genetically and Biologically Distinct Subgroup of Mass-Forming Type Intrahepatic Cholangiocarcinoma, USCAP 113th Annual Meeting, Maryland, USA, 2024.03
Miura E, Emoto K, Abe T, Hashiguchi A, Hishida T, Asakura K, Sakamoto M: Spatial Analysis of Lung Adenocarcinoma Histological Subtyping; Establishment of Artificial Intelligence Model and Its Application to Whole Slide Image, USCAP 113th Annual Meeting, Maryland, USA, 2024.03
Ishii M: Efficacy and safety of arterial infusion chemotherapy in patients with Child–Pugh class B, The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver, Kyoto, Japan, 2024.03
Ishii M: Hepatic arterial infusion is effective in patients with unresectable colorectal liver metastases refractory to standard systemic chemotherapy, The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver, A retrospective cohort study, Kyoto, Japan, 2024.03
